Concord Biotech Ltd (RITES) share price
Concord Biotech Ltd (RITES) is listed in the Pharmaceuticals industry (Healthcare sector). It trades at ₹203.5 (-3% on the day), with a market capitalisation of ₹9,794.84 crore. Its PE ratio is 23.45 on EPS of ₹8.68. The 52-week range is ₹175 – ₹259.7, and the stock is 21.64% below its 52-week high.
| Share price | ₹203.5 |
|---|---|
| Day change | -3% |
| Market cap | ₹9,794.84 Cr |
| PE ratio | 23.45 |
| EPS | ₹8.68 |
| 52-week high | ₹259.7 |
| 52-week low | ₹175 |
| Face value | 1 |
Peers in Pharmaceuticals
- SUN PHARMACEUTICAL INDUSTRIES LTD. share price – ₹1,743
- DIVI'S LABORATORIES LTD. share price – ₹9,087
- TORRENT PHARMACEUTICALS LTD. share price – ₹4,558.7
- Laurus Labs Ltd share price – ₹2,069
- Zydus Lifesciences Ltd share price – ₹1,113.9
- CIPLA LTD. share price – ₹1,324.1
- AUROBINDO PHARMA LTD. share price – ₹1,621.4
- Mankind Pharma Ltd share price – ₹2,253.2